Skip to main content
OTLKHealthcare

Outlook Therapeutics Inc (OTLK) Insider Trading

In the last 90 days, 4 Outlook Therapeutics Inc (OTLK) insiders reported 4 open-market purchases totaling $4,999,999 and no sales. The most recent open-market purchase was reported on Aug 14, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$4,999,999
Corporate buyers
4
Latest transaction
Aug 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 14, 2026Lawrence A KenyonChief Financial OfficerOpen Market Purchase101,010$0.00$0.00
Aug 14, 2026Robert Charles JahrChief Executive OfficerOpen Market Purchase151,515$0.00$0.00
Aug 12, 2026Ghiath M. SukhtianDirector / 10% OwnerOpen Market Purchase2,525,252$0.99$2,499,999
Aug 12, 2026GMS Ventures & InvestmentsDirector / 10% OwnerOpen Market Purchase2,525,252$0.99$2,499,999
Jul 29, 2026Faisal Ghiath SukhtianCorporate insiderOpen Market Purchase95,398$1.05$99,996
Jun 2, 2026Yezan Munther HaddadinCorporate insiderOpen Market Purchase29,000$0.83$24,145
May 28, 2026Ghiath M. SukhtianDirector / 10% OwnerOpen Market Purchase8,539,709$0.59$5,000,000
May 28, 2026GMS Ventures & InvestmentsDirector / 10% OwnerOpen Market Purchase8,539,709$0.59$5,000,000
May 27, 2026Faisal Ghiath SukhtianCorporate insiderOpen Market Purchase122,174$0.41$50,006
May 26, 2026Yezan Munther HaddadinCorporate insiderOpen Market Purchase34,000$0.44$14,960

Common questions

OTLK insider trading FAQ

Are OTLK insiders buying or selling?
Over the last 90 days, OTLK insiders were net buyers, reporting $4,999,999 of open-market purchases and $0.00 of sales.
When was the last OTLK insider purchase?
The most recent open-market purchase of Outlook Therapeutics Inc stock by an insider was reported on Aug 14, 2026, one of 4 purchases in the last 90 days.
Where does OTLK insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Outlook Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.